Brain diseases keep a slow calendar. Parkinson’s has no cure, and the research behind any future treatment spans genetics, biomarkers, disease mechanisms and years of patient study. J-P Conte picked a funding tool built for that timeline.
Through the J-P Conte Family Foundation, he gave the University of California, San Francisco $5 million in November 2024 to create two endowed professorships in the Department of Neurology, both aimed at Parkinson’s and other neurodegenerative disorders. Conte is the founder and managing partner of his family office, Lupine Crest Capital.
A Gift Designed to Continue
An endowed professorship isn’t a one-time grant. The principal is kept invested, and the earnings support a faculty member’s research and teaching year after year, well beyond any single project. In a field where progress accumulates slowly, that continuity carries real weight.
The choice was personal, too. Conte’s father, Pierre, was diagnosed with Parkinson’s in his mid-70s and was cared for by UCSF physicians. “UCSF is an incredible place – the #1 recipient of NIH funding, with some of the most highly regarded clinician-scientists working to improve treatments for Parkinson’s and other diseases,” Conte said in remarks published by the university.
Why Neurodegenerative Research Needs Time
Diseases of the brain resist quick answers. Scientists have to track how conditions develop, test ideas that can take years to confirm, and build on findings that arrive gradually. Steady funding lets that work continue without a scramble for the next grant.
Endowments answer that need, which is why Conte set up his UCSF gift as continuing support rather than a single grant. The two professorships give the university a lasting base for brain research, one that can outlast any single funding cycle.
Backing the People Behind the Research
An endowed chair supports a scientist and a career, and that difference matters. A researcher who isn’t stuck in the constant hunt for renewal can take on harder, longer questions, follow a promising lead wherever it runs, and mentor the graduate students who’ll carry the work forward once a short grant would have ended.
Jean-Pierre Conte aimed his gift at exactly that kind of stability. His support gives two UCSF neurologists room to pursue treatments for the long haul, without the interruptions that come when funding lapses between cycles. Progress against Parkinson’s tends to come in increments, and he funded the patience to chase them. That’s a bet on people and time, and it’s the kind he’s comfortable making.
